Posts by: Leonor Mateus Ferreira

Leonor Mateus Ferreira

Leonor is an emerging, young journalist who writes daily for BioNews Texas, covering business, science, and health news. She holds a bachelor’s degree in Communication and post-graduate degree in Multiplatform Journalism. She is particularly interested in politics and current affairs, and is currently studying for a masters degree in economics and public policies.

February 6, 2015February 6, 2015

Harbor Village Center Advocates for Syringe Exchange Programs to Reduce HCV/HIV Spread

News

Drug addiction is a national concern that has driven an increase in syringe exchange programs dedicated to providing safer practices, and reduce the spread of infectious diseases, such as hepatitis C or HIV. ... Read more

February 5, 2015February 5, 2015

Hepatitis B Foundation Welcomes New Board Members: Craig Esterly and Wayne Yetter

News

The Hepatitis B Foundation has invited engineer and business owner Craig Esterly, and pharmaceutical industry executive Wayne Yetter to join the Board of Directors. Esterly and Yetter will assist the Foundation with its mission, as the U.S.’s only nonprofit ... Read more

January 26, 2015January 26, 2015

Gilead’s Hepatitis C Treatment Sofosbuvir Rejected in India

News

Gilead Sciences, Inc.‘s application to commercialize novel hepatitis C treatment sofosbuvir in India has been rejected by the country’s patent office, as reported by Reuters. The refusal may open a new ... Read more

January 23, 2015January 23, 2015

Arrowhead’s Chronic HBV Infection Therapy Study Approved

News

Arrowhead Research Corporation has been cleared to start its modified multiple-dose study of ARC-520 in patients who suffer from chronic hepatitis B infection by the U.S. Food and Drug Administration (FDA). The ... Read more

January 19, 2015January 19, 2015

EB Pharma to Start Hepatitis D Therapy Study with Janssen

News

A subsidiary of Eiger BioPharmaceuticals, Inc., EB Pharma, LLC., has announced the execution of an agreement with Janssen Pharmaceutical NV, focused on the exclusive licensing of tipifarnib, a potential new therapy for the ... Read more

January 12, 2015January 12, 2015

HIV-HCV Co-Infection Does Not Cause Neurocognitive Impairment According to Study

News

HIV patients are not at risk of neurocognitive impairment from a co-infection of hepatitis C virus (HCV), according to a study, titled, “Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people” conducted ... Read more

January 9, 2015January 9, 2015

Hepatitis C Treatment Response Affected by Genetic Interferon Activity

Hepatitis A, News

While hepatitis A has a wide range of available treatment options, not all patients are cured of the disease. A recent study from the Aarhus University in Denmark attempted to understand this ... Read more

January 8, 2015January 8, 2015

Awareness May Prevent Losing HCV Patients in Health-Care System

Hepatitis C, News

Patients suffering from hepatitis C virus (HCV) infection, at times, end up lost between separate stages of health care for the management of their disease, according to a recent study ... Read more

January 7, 2015January 7, 2015

NICE Supports VTq Diagnostic and Monitoring Device for Hepatitis-related Liver Fibrosis

News

The British National Institute for Health and Care Excellence (NICE) is working on releasing draft guidance supporting the use of the device Virtual Touch Quantification (VTq) by Siemens Healthcare Global as an improved diagnostic and ... Read more

January 6, 2015January 6, 2015

Study Reveals Great Age and Race Disparities in Hepatitis C-Related Deaths

News

The communities with highest public health needs in the state of Massachusetts were identified by a geospatial study conducted at Tufts University School of Medicine, focused on both HIV/AIDS and hepatitis C that revealed great disparities ... Read more